David G. Hunter, MD, PhD is Ophthalmologist-in-Chief and the Richard M. Robb Chair of Ophthalmology at Boston Children’s Hospital, President of the Children’s Hospital Ophthalmology Foundation, Professor and Vice Chair of Ophthalmology at Harvard Medical School, and Chairman of the Board of Rebion, Inc. Dr. Hunter obtained a Bachelor of Science in electrical engineering (Rice University), an MD and Cell Biology PhD (Baylor College of Medicine) and completed an ophthalmology residency (Harvard / Mass Eye & Ear) and pediatric ophthalmology fellowship (Johns Hopkins / Wilmer Institute). Under his leadership, the Department of Ophthalmology at Boston Children’s Hospital has grown to become the world’s largest pediatric ophthalmology department, with 44 full-time faculty including pediatric subspecialists and vision researchers in nearly every aspect of ophthalmology.
Dr. Hunter’s has an active clinical and surgical practice caring for children and adults with strabismus (misaligned eyes.) He is co-author of two ophthalmology textbooks, and his lecture series on optics and refraction is available free of charge in podcast form for ophthalmologists-in-training around the world. He has served as Editor-in-Chief of the Journal of the American Association for Pediatric Ophthalmology and Strabismus and Vice President of the Association for Research in Vision and Ophthalmology (ARVO). He is currently Senior Honor Awardee of the American Academy of Ophthalmology, Gold Fellow of ARVO, and Senior Fellow of the Institute of Electrical and Electronics Engineers. Named in 2012 by the Boston Globe as one of Massachusetts’ 12 Top Innovators, Dr. Hunter is also founder of Rebion, Inc., a medical device company marketing the FDA-cleared blinq™ pediatric vision screener and developing HITT™, transformative technology for evaluation of traumatic brain injury.